From CAR-T to the Lab: Exploring the Future of Antibody Affinity Maturation
Introduction In current years, the field of biotechnology has noticed an remarkable surge in resourceful cures, noticeably in immunotherapy. One impressive advancement is the building of CAR-T (Chimeric Antigen Receptor T-cellular) treatment, which has reworked
